Population prevalence and control of cardiovascular risk factors: What electronic medical records tell us

Atencion Primaria

Volumn 46, Issue 1, 2014, Pages 15-24

  Catalán Ramos, Arantxa ^a,b   Verdú, Jose M ^b,c   Grau, María ^d   Iglesias Rodal, Manuel ^b   Del Val García, José L ^b,e   Consola, Alicia ^f   Comin, Eva ^b  

^a Agència de Qualitat i Avaluació Sanitàries de Catalunya ^*  (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^f Aplicaciones en Informática Avanzada AIA S L   (Spain)

Author keywords

Diabetes mellitus type 2; Electronic Health Records; Hypercholesterolemia; Hypertension; Prevalence; Primary health care

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DATA BASE; DISEASE CONTROL; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREVALENCE; PRIMARY MEDICAL CARE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84893692925     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2013.06.004     Document Type: Article

References (41)

1. World Health Statistics. Monograph on the Internet 2000 World Health Organization Geneva Available from: http://www.who.int/ncd-surveillance/ infobase/web/InfoBaseCommon/ [cited 01.08.06]
2. INEbase Instituto Nacional de Estadística (INE). Available from: http://www.ine.es/inebmenu/indice.htm [cited 17 Ago 2012].
3. I.R. Dégano, R. Elosua, and J. Marrugat Epidemiology of acute coronary syndrome in Spain: estimation of the number of cases and trends from 2005 to 2049 Rev Esp Cardiol 66 2013 472 481
4. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum, and F. Lanas et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
5. D.C Goff Jr., L. Brass, L.T. Braun, J.B. Croft, J.D. Flesch, and F.G. Fowkes et al. Essential features of a surveillance system to the support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease Circulation 115 2007 127 155
6. R. Ramos, E. Balló, J. Marrugat, R. Elosua, J. Sala, and M. Grau et al. Validity for use in research on vascular diseases of the SIDIAP (information system for the development of research in primary care): the EMMA study Rev Esp Cardiol 65 2012 29 37
7. A. Catalán-Ramos Informatización de la prescripción farmacológica FMC 11 2004 97 99
8. E. Comín, A. Catalán-Ramos, J.M. Verdú, M. Iglesias-Rodal, J.L. del Val, and M. Grau et al. Impact of the implementation of electronic guidelines for cardiovascular prevention in primary care: study protocol Inform Prim Care 20 2012 129 139
9. R. Gabriel, M. Alonso, A. Segura, M.J. Tormo, L.M. Artigao, and J.R. Banegas et al. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study Rev Esp Cardiol 61 2008 1030 1040
10. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, and T. Vega Alonso et al. Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study Rev Esp Cardiol 64 2011 295 304
11. F. Rodríguez-Artalejo, A. Graciani, P. Guallar-Castillón, L.M. León-Muñoz, M.C. Zuluaga, and E. López-García et al. Rationale and methods of the study on nutrition and cardiovascular risk in Spain (ENRICA) Rev Esp Cardiol 64 2011 876 882
12. B. Bolíbar, F. Fina Avilés, R. Morros, M. Garcia-Gil Mdel, E. Hermosilla, and R. Ramos et al. SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research Med Clin (Barc) 138 2012 617 621
13. J. Marrugat, I. Subirana, E. Comín, C. Cabezas, J. Vila, and R. Elosua et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study J Epidemiol Commun Health 61 2007 40 47
14. E. Comín, P. Solanas, C. Cabezas, I. Subirana, R. Ramos, and J. Gené-Badía et al. Estimating cardiovascular risk in Spain using different algorithms Rev Esp Cardiol 60 2007 693 702
15. O.E. Ahmad, C. Boschi-Pinto, A.D. Lopez, C.J.L. Murray, R. Lozano, and M. Inoue Age standardization of rates: a new WHO standard GPE Discussion Paper Series: No. 31 2000 World Health Organization Geneva
16. Amado Guirado E, Brotons Cuixart C, Dalfo Baque A, Gilbert Llorach E, Pepio Vilaubi JM, Salleras Marco N. Hipertensio arterial. Available from: www.gencat.cat/ics/professionals/guies/docs/guia-hipertensio-completa.pdf
17. Baena-Diez JM, Barcelo Colomer E, Ciurana Misol R, et al. Colesterol i risc coronari. Available from: www.gencat.cat/ics/professionals/guies/ colesterol/colesterol.htm
18. Mata M, Cos FX, Morros R, et al. Abordatge de la diabetes mellitus tipus 2. Available from: www.gencat.cat/ics/professionals/guies/docs/guia-diabetis.pdf
19. D.G. Manuel, J. Lim, P. Tanuseputro, G.M. Anderson, D.A. Alter, and A. Laupacis et al. Revisiting Rose: strategies for reducing coronary heart disease BMJ 332 2006 659 662
20. J.R. Banegas, A. Graciani, J.J. de la Cruz-Troca, L.M. León-Muñoz, P. Guallar-Castillón, and A. Coca et al. Achievement of cardiometabolic goals in aware hypertensive patients in Spain. A nationwide population-based study Hypertension 60 2012 898 905
21. P. Guallar-Castillón, M. Gil-Montero, L.M. León- Muñoz, A. Graciani, A. Bayán-Bravo, and J.M. Taboada et al. Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study Rev Esp Cardiol 65 2012 551 558
22. J.M. Baena-Díez, F.J. Félix, M. Grau, A. Cabrera de León, H. Sanz, and M. Leal et al. Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study Rev Esp Cardiol 64 2011 766 773
23. J. Ferrières The French paradox: lessons for other countries Heart 90 2004 107 111
24. M. Gil, H. Martí, R. Elosúa, M. Grau, J. Sala, and R. Masiá et al. Analysis of trends in myocardial infarction case-fatality, incidence and mortality rates in Girona, Spain, 1990-1999 Rev Esp Cardiol 60 2007 349 356
25. M. Grau, and J. Marrugat Risk functions and the primary prevention of cardiovascular diseases Rev Esp Cardiol 61 2008 404 416
26. R. Grol Successes and failures in the implementation of evidence-based guidelines for clinical practice Med Care 39 8 (Suppl 2) 2001 II46 II54
27. S.H. Woolf, R. Grol, A. Hutchinson, M. Eccles, and J. Grimshaw Potential benefits, limitations, and harms of clinical guidelines BMJ 318 1999 527 530
28. G.C. Rodríguez-Roca, J.L. Llisterri, V. Barrios, F.J. Alonso-Moreno, J.R. Banegas, S. Lou, and A. Matalí en representación de los Grupos de Trabajo de Riesgo Cardiovascular y de Hipertensión Arterial de la Sociedad Española de Medicina Rural y Generalista (SEMERGEN) y de los investigadores del Estudio LIPICAP. Grado de control de la dislipemia en los pacientes españoles asistidos en atención primaria Estudio LIPICAP Clin Invest Arterioscl 18 2006 226 238
29. J.L. Llisterri Caro, G.C. Rodríguez Roca, F.J. Alonso Moreno, J.R. Banegas Banegas, D. González-Segura Alsina, and S. Lou Arnal et al. Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study Med Clin (Barc) 130 2008 681 687
30. D. Orozco-Beltrán, V.F. Gil-Guillen, F. Quirce, J. Navarro-Perez, M. Pineda, and A. Gomez-de-la-Cámara et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain Int J Clin Pract 61 2007 909 915
31. M. Grau, I. Subirana, R. Elosua, P. Solanas, R. Ramos, R. Masia, F. Cordón, J. Sala, D. Juvinyà, C. Cerezo, M. Fitó, J. Vila, M.I. Covas, and J. Marrugat Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain Eur J Cardiovasc Prev Rehabil 14 2007 653 659
32. F. Catalá, G. Sanfélix, C. García, M. Ridao, and S. Peiró Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341 632 participants J Hypertens 30 2011 168 176
33. UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group Diabetes Care 21 1998 87 92
34. I. Vinagre, M. Mata-Cases, E. Hermosilla, R. Morros, F. Fina, and M. Rosell et al. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain) Diabetes Care 35 2012 774 779
35. M. Comaschi, C. Coscelli, D. Cucinotta, P. Malini, E. Manzato, A. Nicolucci SFIDA Study Group-Italian Association of Diabetologists (AMD) Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study Nutr Metab Cardiovasc Dis 15 2005 204 211
36. P.J. O'Connor, J.M. Sperl-Hillen, W.A. Rush, P.E. Johnson, G.H. Amundson, and S.E. Asche et al. Impact of electronic health record clinical decision support on diabetes care: a randomized trial Ann Fam Med 9 2011 12 21
37. S. de Lusignan, N. Hague, J. van Vlymen, and P. Kumarapeli Routinely-collected general practice data are complex, but with systematic processing can be used for quality improvement and research Inform Prim Care 14 2006 59 66
38. A.G. Crawford, C. Cote, J. Couto, M. Daskiran, C. Gunnarsson, and K. Haas et al. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE centricity electronic medical record database Popul Health Manag 13 2010 151 161
39. J.E. Biskupiak, J. Kin, H. Phatak, and D. Wu Prevalence of high-risk cardiovascular conditions and the status of hypertension management among hypertensive adults 65 years and older in the United States: analysis of a primary care electronic medical records database J Clin Hypertens (Greenwich) 12 2010 935 944
40. J.C. Crosson, P.A. Ohman-Strickland, D.J. Cohen, E.C. Clark, and B.F. Crabtree Typical electronic health record use in primary care practices and the quality of diabetes care Ann Fam Med 10 2012 221 227
41. D.G. Manuel, L.C. Rosella, and T.A. Stukel Importance of accurately identifying disease in studies using electronic health records BMJ 341 2010 c4226